Current status of miRNA-targeting therapeutics and preclinical studies against gastroenterological carcinoma - Wikidata - awgldk - TriplyDB

Current status of miRNA-targeting therapeutics and preclinical studies against gastroenterological carcinoma

Current status of miRNA-targeting therapeutics and preclinical studies against gastroenterological carcinoma

http://www.wikidata.org/entity/Q27026846

about

MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics The Therapeutic Targets of miRNA in Hepatic Cancer Stem Cells MicroRNAs and Growth Factors: An Alliance Propelling Tumor Progression miR-155 Overexpression Promotes Genomic Instability by Reducing High-fidelity Polymerase Delta Expression and Activating Error-Prone DSB Repair Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs MicroRNA Expression in the Glaucomatous Retina miR-124 interacts with the Notch1 signalling pathway and has therapeutic potential against gastric cancer Technological advances in precision medicine and drug development.Inflammation-induced miRNA-155 inhibits self-renewal of neural stem cells via suppression of CCAAT/enhancer binding protein β (C/EBPβ) expression.The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment.Targeting VEGF with LNA-stabilized G-rich oligonucleotide for efficient breast cancer inhibition.Diagnostic and therapeutic application of noncoding RNAs for hepatocellular carcinoma.Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel?Identification of aminosulfonylarylisoxazole as microRNA-31 regulators.Recent Advances in Understanding Cholangiocarcinoma.Non-coding RNAs in Various Stages of Liver Disease Leading to Hepatocellular Carcinoma: Differential Expression of miRNAs, piRNAs, lncRNAs, circRNAs, and sno/mt-RNAs.Diagnostic and therapeutic potentials of microRNAs in cholangiopathies miR-193b and miR-30c-1 inhibit, whereas miR-576-5p enhances melanoma cell invasion Suppression of PDHX by microRNA-27b deregulates cell metabolism and promotes growth in breast cancer

P2860

Q26747273-8DD5DC36-D661-4E9B-93A9-9919C6213CAF Q26749450-1D7A5099-E56D-4581-BA76-AAD8B587426B Q26796592-AE06A793-BA66-4089-B045-CF966314236A Q28272973-043F522C-719B-4944-B348-5FD11238F744 Q30367369-7F73BF5B-F8A1-40D8-9975-B364B60C97F2 Q36384654-5658C91F-0CB5-485B-9EEF-FC5CFE184696 Q36504303-35C70320-A8AB-424C-8DC8-D97BA87B4706 Q37244501-0030942C-A584-4A86-AE3E-C6C185543082 Q37736251-8CB3D897-E304-45A0-9EC5-92E4B7EA5003 Q38213933-4840FBA8-A16A-406C-8379-3C3B80888C76 Q38299065-18D92B7D-D171-4924-95F5-5E2AB381A178 Q38334014-C6934BF1-2291-41A8-843B-10A5DD090A37 Q38554626-F36F9F60-2F0E-4CCE-A8F6-9872D3B03FDB Q41255588-AEE15DBE-9936-4C1B-882D-C0657156D522 Q47165549-BCDF3CD0-34CA-4ADB-AE2E-BE1989DF7470 Q54943797-E528B0EC-0A78-4B28-9ACB-E8B98089B7C0 Q57128794-15AA5DE6-F1B7-48C5-B5BD-1971CE6A3FA8 Q57168333-CD2C9CCF-F227-4270-97F6-F10A3E35C474 Q59123167-2917595E-618C-416B-A40A-DAE99FA84D25

P2860

Current status of miRNA-targeting therapeutics and preclinical studies against gastroenterological carcinoma

http://www.wikidata.org/entity/Q27026846

description

2013 nî lūn-bûn

@nan

2013 թուականին հրատարակուած գիտական յօդուած

@hyw

2013 թվականին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

name

Current status of miRNA-target ...... gastroenterological carcinoma

@ast

Current status of miRNA-target ...... gastroenterological carcinoma

@en

Current status of miRNA-target ...... gastroenterological carcinoma

@nl

type

label

Current status of miRNA-target ...... gastroenterological carcinoma

@ast

Current status of miRNA-target ...... gastroenterological carcinoma

@en

Current status of miRNA-target ...... gastroenterological carcinoma

@nl

prefLabel

Current status of miRNA-target ...... gastroenterological carcinoma

@ast

Current status of miRNA-target ...... gastroenterological carcinoma

@en

Current status of miRNA-target ...... gastroenterological carcinoma

@nl

P1433

Q27026846-B9F20A6C-2B96-426D-80F0-3BDEAE0FCD96

P1476

Q27026846-DA02F339-DC16-43EE-907C-3555BC3B9716

P2093

Q27026846-02A40A71-539D-4CA6-B381-0AF6D5A81865

Q27026846-44740226-7751-4983-8D8F-F7CC209DF90D

Q27026846-7A58299F-81E7-47B4-9620-D3CFDF8888E2

Q27026846-CD5468D4-EDA6-4E47-8CE8-63245B4F265B

Q27026846-F053915C-2761-4D13-97B8-F547C4384D1D

P2860

Q27026846-0336910C-4079-4E9C-A9A1-365ADCBE1C76

Q27026846-05702F88-A3F4-4E9F-B970-EC8BE6E02899

Q27026846-06A25730-CCF2-4322-8E7A-AEE37B365250

Q27026846-08C2982F-F69B-4B78-B1AE-610F5E387CB6

Q27026846-09E433A2-A32C-4383-B222-3DFE56AD9B85

Q27026846-0ABF7CE0-530E-4204-8CB1-13F315B63AFA

Q27026846-0AC858A1-2B7F-442B-A42F-7F9152655B79

Q27026846-0B852EBB-00E9-4617-8D02-9F926865A935

Q27026846-0C5AF9D8-6B35-4EB6-A1FD-2A922B9B1359

Q27026846-14369D28-1E67-4D30-8303-0DD0383447F6

P2888

Q27026846-B9520AE0-6AEA-4CDE-AC7B-DF484F0FA6EF

P304

Q27026846-A2CBB25D-C083-4CEC-9366-E4CF3A293F2F

P31

Q27026846-4CB89824-0576-4AB9-94EC-6114AC6A148F

P3181

Q27026846-D77C9D62-A2F4-41F6-BB81-D6DEFDBD6268

P356

Q27026846-B36418FD-B150-47AC-A311-B8DFE8845443

P407

Q27026846-0411BA60-5E23-4415-AA9D-84B9F3304C67

P478

Q27026846-2A8BCB40-C073-4C31-BCF9-97AEE5848F0E

P50

Q27026846-68E8BD01-5E80-462A-AB44-9B7ED0608CA9

Q27026846-E55166BB-C131-4784-B2F3-70F7043506B4

P577

Q27026846-3FEFC720-440A-42A3-819E-FCF05F51D7C0

P5875

Q27026846-C0D9753F-8C73-477E-8D73-DB35CF1AB9AE

P6179

Q27026846-49A6596E-99C3-4EAA-A3A5-2437841F1E16

P698

Q27026846-9829FA0F-934E-4ADA-8C61-486C29A040BA

P921

Q27026846-3E1B30A3-AAF9-476E-85E4-E9049E38655E

P932

Q27026846-BFAEC449-3DBB-462F-A939-BB63AE3CE3B7

P3181

P356

P1433

Molecular and cellular therapies

P1476

Current status of miRNA-target ...... gastroenterological carcinoma

@en

P2093

Akemi Takata

http://www.w3.org/2001/XMLSchema#string

Chikako Shibata

http://www.w3.org/2001/XMLSchema#string

Motoko Ohno

http://www.w3.org/2001/XMLSchema#string

Takahiro Kishikawa

http://www.w3.org/2001/XMLSchema#string

Takeshi Yoshikawa

http://www.w3.org/2001/XMLSchema#string

P2860

The nuclear RNase III Drosha initiates microRNA processing

The Drosha-DGCR8 complex in primary microRNA processing

Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma

MicroRNAs: target recognition and regulatory functions

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma

miR-221 overexpression contributes to liver tumorigenesis

A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis

Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver

MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib

P2888

P304

5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1330208

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/2052-8426-1-5

http://www.w3.org/2001/XMLSchema#string

P407

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Motoyuki Otsuka

P577

2013-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277978595

http://www.w3.org/2001/XMLSchema#string

P6179

1032957660

http://www.w3.org/2001/XMLSchema#string

P698

26056570

http://www.w3.org/2001/XMLSchema#string

P921

gastroenterology

P932

4448951

http://www.w3.org/2001/XMLSchema#string